Insider trading

Period: 12 months Type of trade: Sold × Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

5,108 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

5,108 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

5,108 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

5,108 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
5,108 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
5,108 decisions over 12 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

5,108 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
10 Sep 2026
HRT FINANCIAL LP 10% owner
Sold at will
$1.86K 5,048 at 0.37
79.3%
Sold half or more
9 Sep 2026
Sold at will
$106.12M 9,250,000 at 11.47
100%
Sold half or more
9 Sep 2026
Larson Keith D General Counsel and Secretary
Sold on a plan
$28.69M 1,885,804 at 15.21
100%
Sold half or more
9 Sep 2026
Silver Lake Partners IV, L.P. Director · indirect
Sold at will 17×
$28.48M 52,708 at 540.39
55.7%
Sold half or more
9 Sep 2026
SL SPV-2, L.P. Director · indirect
Sold at will 17×
$25.99M 48,097 at 540.39
50.4%
Sold half or more
9 Sep 2026
Sold at will 17×
$14.93M 27,629 at 540.39
53.0%
Sold half or more
9 Sep 2026
Tsao David Chief Technology Officer
Sold on a plan 2×
$1.98M 20,000 at 98.77
95.2%
Sold half or more
9 Sep 2026
King Ryan A Co-Founder · indirect
Sold on a plan
$1.49M 42,421 at 35.15
100%
Sold half or more
9 Sep 2026
Butcher Stephanie Senior Managing Director
Sold at will
$1.46M 45,095 at 32.28
81.5%
Sold half or more
9 Sep 2026
Silbermann Benjamin Director · indirect
Sold on a plan
$939.49K 46,875 at 20.04
100%
Sold half or more
9 Sep 2026
Sold at will 17×
$580.91K 1,075 at 540.38
100%
Sold half or more
9 Sep 2026
Sold at will
$388.77K 7,623 at 51.00
100%
Sold half or more
9 Sep 2026
Sold at will 17×
$262.63K 486 at 540.40
100%
Sold half or more
9 Sep 2026
HRT FINANCIAL LP 10% owner
Sold at will 2×
$174.01K 60,343 at 2.88
76.8%
Sold half or more
9 Sep 2026
Zecchini Christopher J Chief Accounting Officer
Sold at will
$63.79K 2,740 at 23.28
76.4%
Sold half or more
8 Sep 2026
Wang Xiaodong Director
Sold on a plan 8×
$13.37M 38,287 at 349.10
100%
Sold half or more
8 Sep 2026
Intrator Michael N CEO and President · indirect
Sold on a plan 12×
$10.78M 107,692 at 100.08
100%
Sold half or more
8 Sep 2026
Larson Keith D General Counsel and Secretary
Sold on a plan
$6.98M 464,196 at 15.05
100%
Sold half or more
8 Sep 2026
Kim Lorence H. Director · indirect
Sold on a plan 7×
$3.59M 17,090 at 209.82
100%
Sold half or more
8 Sep 2026
BAKER DANIEL A Director
Sold at will 2×
$2.15M 21,140 at 101.49
54.1%
Sold half or more
8 Sep 2026
Lynch Thomas P. See Remarks
Sold on a plan 13×
$2.00M 20,000 at 99.99
96.6%
Sold half or more
8 Sep 2026
Brown Sam D. SEVP, Chief Banking Officer
Sold on a plan
$1.45M 30,000 at 48.42
53.0%
Sold half or more
8 Sep 2026
Budur Kumar CHIEF MEDICAL OFFICER
Sold at will 3×
$1.22M 28,454 at 42.96
68.5%
Sold half or more
8 Sep 2026
Senn Andrew President, Growth & Innovation
Sold at will
$1.19M 9,408 at 126.30
63.5%
Sold half or more
8 Sep 2026
Silbermann Benjamin Director · indirect
Sold on a plan
$940.56K 46,875 at 20.07
100%
Sold half or more
8 Sep 2026
Bodenhoff Mads SVP & PAO
Sold at will
$810.57K 3,000 at 270.19
100%
Sold half or more
8 Sep 2026
Sold at will 21×
$589.79K 1,119 at 527.07
100%
Sold half or more
8 Sep 2026
Aquilino Brian Chief Operating Officer
Sold at will
$313.46K 6,667 at 47.02
100%
Sold half or more
8 Sep 2026
Sold at will 21×
$265.12K 503 at 527.07
100%
Sold half or more
8 Sep 2026
MELTZER CAROL EVP, Gen. Counsel & Secretary
Sold at will
$187.44K 4,000 at 46.86
72.7%
Sold half or more
8 Sep 2026
Jubran Sami EVP Chief Finance Officer
Sold at will 2×
$90.33K 3,020 at 29.91
100%
Sold half or more
8 Sep 2026
KRASNOW TODD Director · indirect
Sold on a plan 2×
$87.14K 2,000 at 43.57
100%
Sold half or more
8 Sep 2026
Tiran Assaf EVP Cross Suez & Atlantic BU
Sold at will
$69.84K 2,312 at 30.21
100%
Sold half or more
8 Sep 2026
Sold at will
$36.10K 2,842 at 12.70
90.4%
Sold half or more
8 Sep 2026
TOTH TERENCE J Trustee
Sold at will
$34.15K 4,464 at 7.65
100%
Sold half or more
8 Sep 2026
HRT FINANCIAL LP 10% owner
Sold at will
$29.00K 40,841 at 0.71
60.1%
Sold half or more
8 Sep 2026
Elimelech Arik EVP HR & Organization
Sold at will
$13.73K 458 at 29.99
100%
Sold half or more
4 Sep 2026
GARRETT MARK Director
Sold at will
$17.50M 50,000 at 350.00
83.2%
Sold half or more
4 Sep 2026
Chuang Hao-Yuan Chief Financial Officer
Sold on a plan 14×
$9.28M 49,433 at 187.64
52.9%
Sold half or more
4 Sep 2026
Feldman Andrew D. CEO, President
Sold at will 16×
$7.88M 37,441 at 210.46
69.0%
Sold half or more
4 Sep 2026
Chen Xu Chief Marketing Officer
Sold at will
$3.40M 400,000 at 8.50
72.3%
Sold half or more
4 Sep 2026
Gullo Michelle L Senior Vice President & CHRO
Sold at will
$1.50M 9,874 at 152.29
51.3%
Sold half or more
4 Sep 2026
Richardson Julie Director
Sold on a plan 2×
$1.19M 5,625 at 212.25
63.9%
Sold half or more
4 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer
Sold on a plan 2×
$942.64K 10,773 at 87.50
80.9%
Sold half or more
4 Sep 2026
Sold at will 15×
$583.91K 1,120 at 521.35
100%
Sold half or more
4 Sep 2026
Sold at will
$550.10K 10,000 at 55.01
64.8%
Sold half or more
4 Sep 2026
Erstad Dean Everett Senior VP Sales & Marketing
Sold at will
$327.18K 1,587 at 206.16
72.3%
Sold half or more
4 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer · indirect
Sold on a plan 2×
$278.25K 3,180 at 87.50
66.7%
Sold half or more
4 Sep 2026
Sold at will 15×
$262.76K 504 at 521.35
100%
Sold half or more
4 Sep 2026
Bernstein Harold President, R&D & CMO
Sold on a plan
$254.50K 9,705 at 26.22
100%
Sold half or more
Showing 301–350 of 5,108. ← Newer Page 7 of 103 Older →